Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04534322 |
Title | Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma (sEAPort) |
Acronym | sEAPort |
Recruitment | Approved for marketing |
Gender | both |
Phase | Expanded access |
Variant Requirements | No |
Sponsors | Oncopeptides AB |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Highlands Oncology Group | Springdale | Arkansas | 72762 | United States | Details | |
Beacon Cancer Care | Coeur d'Alene | Idaho | 83814 | United States | Details | |
University of Illinois Cancer Center | Chicago | Illinois | 60612 | United States | Details | |
Weill Cornell Medicine - Multiple Myeloma Center | New York | New York | 10065 | United States | Details | |
Gabrail Cancer Center | Canton | Ohio | 44718 | United States | Details | |
Oregon Health & Science University | Portland | Oregon | 97239 | United States | Details | |
Prisma Health Cancer Institute | Greenville | South Carolina | 29605 | United States | Details | |
Texas Oncology | Dallas | Texas | 75230 | United States | Details | |
Community Cancer Trials of Utah | Ogden | Utah | 84405 | United States | Details | |
Virginia Cancer Specialists, PC | Fairfax | Virginia | 22031 | United States | Details | |
Northwest Medical Specialties | Tacoma | Washington | 98405 | United States | Details |